Behavioral Parenting Skills As A Novel Target for Improving Pediatric Medication Adherence

Inclusion Criteria

• •INCLUSION:
• •Parent of a child diagnosed within the past month with acute lymphoblastic leukemia (ALL)
• •Pediatric patient's age 3 - 9.
• •\* If present during the home visit, any other child, ages 0-18
• •Child on therapy that includes oral mercaptopurine (6-MP) administration
• •Parent age 18 - NA (No Limit)
• •Parent should have verbal English fluency
• •Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
• •The following special populations may be included in this study:
• •* Pregnant women: due to the design of this behavioral research, pregnant and fetuses should incur no elevated risk from participation.
• •Children under age 18 will participate in one aspect of the study, the video recording of medication administration.
• •\* Other children (not the pediatric patient) under age 18 that are present during the time of the home visit
• •Exclusion:
• •Pediatric patient is on therapy that does not include oral 6-MP administration
• •Cognitively impaired adults/adults with impaired decision-making capacity
• •Pediatric patients who are not yet adults (infants under the age of 3, children over 9 years, teenagers)
• •Prisoners